268
Views
7
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs for urothelial carcinoma

, MD &
Pages 477-494 | Published online: 06 Nov 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Clarisse R Mazzola, Khurram M Siddiqui, Michele Billia & Joseph Chin. (2014) Dovitinib: rationale, preclinical and early clinical data in urothelial carcinoma of the bladder. Expert Opinion on Investigational Drugs 23:11, pages 1553-1562.
Read now

Articles from other publishers (6)

Hung-En Chen, Ji-Fan Lin, Yi-Chia Lin, Shen-I Wen, Shan-Che Yang, Te-Fu Tsai, Kuang-Yu Chou & I-Sheng Thomas Hwang. (2018) Chloroquine induces lysosomal membrane permeability-mediated cell death in bladder cancer cells. Formosan Journal of Surgery 51:4, pages 133-141.
Crossref
Marie-Lisa Eich, Lars Dyrskjøt & George J. Netto. (2017) Toward personalized management in bladder cancer: the promise of novel molecular taxonomy. Virchows Archiv 471:2, pages 271-280.
Crossref
George J. Netto & Laura J. Tafe. (2016) Emerging Bladder Cancer Biomarkers and Targets of Therapy. Urologic Clinics of North America 43:1, pages 63-76.
Crossref
Tao Yang, Runlin Shi, Lei Chang, Kun Tang, Ke Chen, Gan Yu, Yuanfeng Tian, Yonglian Guo, Wei He, Xiaodong Song, Hua Xu & Zhangqun Ye. (2015) Huachansu suppresses human bladder cancer cell growth through the Fas/Fasl and TNF- alpha/TNFR1 pathway in vitro and in vivo. Journal of Experimental & Clinical Cancer Research 34:1.
Crossref
Ilguk Min, Kangpa Lee, Haeryong Chang & Jinyoung Moon. (2015) Pinus densiflora Gnarl Inhibits Migration through Suppression of Protein Kinase C in C6 Glioma Cells. Korean Journal of Acupuncture 32:2, pages 51-58.
Crossref
Ashesh B. Jani, Jason A. Efstathiou & William U. Shipley. (2015) Bladder Preservation Strategies. Hematology/Oncology Clinics of North America 29:2, pages 289-300.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.